Abstract: Prognostics and health management aims to use on-line sensor data to monitor and predict current and future health conditions of degraded systems and components. Nowadays, constructing ...
Thanks to new settlement agreements with three generic drug makers, Gilead Sciences has extended the expected life span of its flagship HIV treatment Biktarvy by as many years. Gilead has struck ...
The FDA has authorized another generic variation of mifepristone. Drugmaker Evita Solutions says the version of this drug will be released in 2026. Last year, the Supreme Court refused to limit access ...
US regulators have approved an additional generic version of the abortion pill mifepristone, a normally routine move that nevertheless angered anti-abortion activists. A number of conservative figures ...
The FDA's pilot program aims to expedite reviews for domestically manufactured generic drugs, enhancing the U.S. pharmaceutical supply chain and reducing costs. The initiative requires ANDA applicants ...
ANN ARBOR, Mich., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Dr. Reddy’s Laboratories, Inc. and its affiliate Dr.
The Food and Drug Administration on Tuesday quietly approved a generic form of mifepristone, one of the two medications used in most U.S. abortions. That makes the drug, from the company Evita ...
Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups aligned with the Trump ...
Reshoring generic pharmaceutical production is essential in today’s era of geopolitical instability and heightened awareness surrounding national health security. And it is possible—if done right. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback